-+ 0.00%
-+ 0.00%
-+ 0.00%

SCRIBE THERAPEUTICS - Q2 2026 NET LOSS $6.50 MLN OR $2.62 PER SHARE VS $9.90 MLN OR $4.08 PER SHARE IN Q2 2025

Reuters·09/02/2026 20:05:02

Please log in to view news